Treatment failure in hepatitis C: Mechanisms of non-response

被引:42
作者
Tai, Andrew W.
Chung, Raymond T. [1 ]
机构
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
Hepatitis C; Interferon; Treatment; Race; Immune system; SUSTAINED VIROLOGICAL RESPONSE; CAUCASIAN AMERICAN PATIENTS; VIRUS-RNA REPLICATION; ANTIVIRAL THERAPY; PLUS RIBAVIRIN; CORE PROTEIN; IN-VITRO; ANTIINTERFERON ANTIBODIES; PEGINTERFERON ALPHA-2B; CYTOKINE SIGNALING-3;
D O I
10.1016/j.jhep.2008.11.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) has evolved remarkable mechanisms that favor viral persistence by interfering with host innate and adaptive immune responses. These same mechanisms are likely to contribute to resistance to exogenously administered interferon used for HCV treatment. We review the host innate and adaptive immune responses in the context of HCV infection as well as the strategies by which these responses are subverted by the virus. In addition, the contribution of host factors, such as race and insulin resistance, to interferon non-responsiveness is discussed. Our progress in understanding the molecular underpinnings of interferon treatment failure in HCV infection has resulted in several promising and novel treatment strategies for HCV treatment non-responders. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:412 / 420
页数:9
相关论文
共 55 条
  • [1] Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection
    Auffermann-Gratzinger, S
    Keeffe, EB
    Levy, S
    [J]. BLOOD, 2001, 97 (10) : 3171 - 3176
  • [2] IFN-α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3
    Bode, JG
    Ludwig, S
    Ehrhardt, C
    Erhardt, A
    Albrecht, U
    Schaper, F
    Heinrich, PC
    Häussinger, D
    [J]. FASEB JOURNAL, 2003, 17 (01) : 488 - +
  • [3] Cheng NP, 2005, CHINESE PHYS, V14, P1444, DOI 10.1088/1009-1963/14/7/031
  • [4] Analysis of ribavirin mutagenicity in human hepatitis C virus infection
    Chevaliez, Stephane
    Brillet, Rozenn
    Lazaro, Ester
    Hezode, Christophe
    Pawlotsky, Jean-Michel
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (14) : 7732 - 7741
  • [5] Race, insulin resistance and hepatic steatosis in chronic hepatitis C
    Conjeevaram, Hari S.
    Kleiner, David E.
    Everhart, Jay E.
    Hoofnagle, Jay H.
    Zacks, Steven
    Afdhal, Nezam H.
    Wahed, Abdus S.
    [J]. HEPATOLOGY, 2007, 45 (01) : 80 - 87
  • [6] Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
    Conjeevaram, Hari S.
    Fried, Michael W.
    Jeffers, Lennox J.
    Terrault, Norah A.
    Wiley-Lucas, Thelma E.
    Afdhal, Nezam
    Brown, Robert S.
    Belle, Steven H.
    Hoofnagle, Jay H.
    Kleiner, David E.
    Howell, Charles D.
    [J]. GASTROENTEROLOGY, 2006, 131 (02) : 470 - 477
  • [7] Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy
    Donlin, Maureen J.
    Cannon, Nathan A.
    Yao, Ermei
    Li, Jia
    Wahed, Abdus
    Taylor, Milton W.
    Belle, Steven H.
    Di Bisceglie, Adrian M.
    Aurora, Rajeev
    Tavis, John E.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (15) : 8211 - 8224
  • [8] S-adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro
    Duong, FHT
    Christen, V
    Filipowicz, M
    Heim, MH
    [J]. HEPATOLOGY, 2006, 43 (04) : 796 - 806
  • [9] Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A
    Duong, FHT
    Filipowicz, M
    Tripodi, M
    La Monica, N
    Heim, MH
    [J]. GASTROENTEROLOGY, 2004, 126 (01) : 263 - 277
  • [10] Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
    Feld, Jordan J.
    Nanda, Santosh
    Huang, Ying
    Chen, Weiping
    Cam, Maggie
    Pusek, Susan N.
    Schweigler, Lisa M.
    Theodore, Dickens
    Zacks, Steven L.
    Liang, T. Jake
    Fried, Michael W.
    [J]. HEPATOLOGY, 2007, 46 (05) : 1548 - 1563